aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;;CHEMBL618310;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (plasma);CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL624569;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Observed volume of distribution;CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL628290;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Calculated membrane partition coefficient (Kmemb);CHEMBL1149124;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631962;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Aqueous solubility;CHEMBL1132890;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631377;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1134540;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631379;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;HPLC capacity factor (k);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL633649;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Delta logD (logD6.5 - logD7.4);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL634283;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD6.5);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635170;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant (pKa);CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635931;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL639853;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Fraction ionized (pH 7.4);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL639855;[];;[];;;;;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (plasma);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL638828;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (tissues);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL874960;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Ionization constant (pKa);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL637833;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP) (HPLC);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL637835;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;HPLC capacity factor (k');CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL633098;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Oral bioavailability in human;CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL632931;[];;[];;;;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution in man (IV dose);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL646313;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;The ability concentration.);CHEMBL1133182;Homologous protein target assigned;H;;1;CHEMBL3253;;
CLD0;;;CHEMBL734661;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Binding affinity against human monoclonal antibody (mAb)-11E6;CHEMBL1135516;Molecular target other than protein assigned;M;;1;CHEMBL613294;;
CLD0;;;CHEMBL734662;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Binding affinity against human monoclonal antibody (mAb)-1B3;CHEMBL1135516;Molecular target other than protein assigned;M;;1;CHEMBL613294;;
CLD0;;;CHEMBL734663;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Binding affinity against human monoclonal antibody (mAb)-5C2;CHEMBL1135516;Molecular target other than protein assigned;M;;1;CHEMBL613294;;
CLD0;;;CHEMBL734664;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Binding affinity against human monoclonal antibody (mAb)-7F2;CHEMBL1135516;Molecular target other than protein assigned;M;;1;CHEMBL613294;;
CLD0;;;CHEMBL771537;[];Rattus norvegicus;[];;;10116.0;;Serum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Activity of alkaline phosphatase (ALP) tested in serum of rat when 18 ug/kg of compound was administered intramuscularly;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638229;
CLD0;;;CHEMBL772059;[];Rattus norvegicus;[];;;10116.0;;Serum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Activity tested for the content of calcium in serum of rat when 18 ug/kg of compound was administered intramuscularly when compared to vehicle;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638229;
CLD0;;;CHEMBL772061;[];Rattus norvegicus;[];;;10116.0;;Femur;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage content of calcium in femur tested in the compound using male ICR rats when compared to vehicle;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638194;
CLD0;;;CHEMBL789426;[];Rattus norvegicus;[];;;10116.0;;Femur;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage content of phosphor in femur tested in the compound using male ICR rats;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638194;
CLD0;;;CHEMBL793603;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight of rat body tested after intramuscular administration of 18 ug/kg of compound when compared to vehicle;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL792923;[];Rattus norvegicus;[];;;10116.0;;Femur;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight of rat femur ash tested after intramuscular administration of 18 ug/kg of compound when compared to vehicle;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638194;
CLD0;;;CHEMBL792927;[];Rattus norvegicus;[];;;10116.0;;Femur;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Weight of rat femur tested after intramuscular administration of 18 ug/kg of compound when compared to vehicle;CHEMBL1144960;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638194;
CLD0;;;CHEMBL925051;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient, log P of the compound;CHEMBL1140614;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL925053;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability across PAMPA membrane after 7 hrs;CHEMBL1140614;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL926687;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Oral bioavailability in human;CHEMBL1141299;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;HEK293;CHEMBL993349;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy;CHEMBL1140113;Direct protein target assigned;D;;1;CHEMBL5685;;
CLD0;;Sf9;CHEMBL1006005;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control;CHEMBL1150338;Direct protein target assigned;D;;1;CHEMBL5748;;
CLD0;;;CHEMBL1035433;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total body clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1035434;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;;CHEMBL1043580;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Fraction unbound in human plasma;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL613652;CHEMBL3559721;
CLD0;;;CHEMBL1043581;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043582;[];Homo sapiens;[];;;9606.0;In vivo;Liver;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Hepatic clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3559723;
CLD0;;;CHEMBL1043583;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;;CHEMBL1043584;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Oral bioavailability in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043585;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction absorbed in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043586;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction escaping gut-wall elimination in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043587;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction escaping hepatic elimination in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043588;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Volume of distribution at steady state in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1100461;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Fraction unbound in human plasma;CHEMBL1153781;Non-molecular target assigned;N;;1;CHEMBL613652;CHEMBL3559721;
CLD0;;;CHEMBL1100462;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Volume of distribution at steady state in human;CHEMBL1153781;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;confirmatory;;CHEMBL1614161;[];Schistosoma mansoni;[];;;6183.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)];CHEMBL1201862;Direct protein target assigned;D;485364;7;CHEMBL6110;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614399;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response. (Class of assay: confirmatory) [Related pubchem assays: 914 (Primary screen.), 915 (Primary screen.)];CHEMBL1201862;Direct protein target assigned;D;2120;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1614531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1766;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1613910;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;893;7;CHEMBL4159;;
CLD0;confirmatory;;CHEMBL1614087;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2551;7;CHEMBL1293231;;
CLD0;confirmatory;;CHEMBL1614364;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485290;7;CHEMBL1075138;;
CLD0;;;CHEMBL1614670;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614671;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction unbound in human after iv administration;CHEMBL1614632;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1614673;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mean residence time in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614674;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Half life in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614675;[];Rattus norvegicus;[];;;10116.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in rat after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614676;[];Rattus norvegicus;[];;;10116.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in rat after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614677;[];Canis lupus familiaris;[];;;9615.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in dog after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614678;[];Canis lupus familiaris;[];;;9615.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in dog after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614679;[];Macaca;[];;;9539.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in monkey after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614680;[];Macaca;[];;;9539.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in monkey after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614681;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614682;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614629;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;;CHEMBL1737902;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355];CHEMBL1201862;Default value - Target has yet to be curated;U;493014;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1794311;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855];CHEMBL1201862;Homologous protein target assigned;H;504847;7;CHEMBL1977;;
CLD0;confirmatory;;CHEMBL1794321;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of androgen receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588515;7;CHEMBL1871;;
CLD0;confirmatory;;CHEMBL1794382;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588533;7;CHEMBL2034;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794560;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588516;7;CHEMBL1871;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;;;CHEMBL1908080;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A1;CHEMBL1907987;Direct protein target assigned;D;1;1;CHEMBL1287617;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;confirmatory;MDA-N;CHEMBL1963976;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307532;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;87;7;CHEMBL614078;;
CLD0;confirmatory;SN12C;CHEMBL1963981;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;145;7;CHEMBL614054;;
CLD0;confirmatory;NCI-H23;CHEMBL1963985;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1;7;CHEMBL614997;;
CLD0;confirmatory;ACHN;CHEMBL1963989;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;139;7;CHEMBL614519;;
CLD0;confirmatory;UO-31;CHEMBL1963990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;143;7;CHEMBL614388;;
CLD0;confirmatory;HOP-92;CHEMBL1963991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;13;7;CHEMBL613889;;
CLD0;confirmatory;HL-60;CHEMBL1963994;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;125;7;CHEMBL383;;
CLD0;confirmatory;DU-145;CHEMBL1964017;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;43;7;CHEMBL613508;;
CLD0;confirmatory;SF-539;CHEMBL1964018;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;49;7;CHEMBL614860;;
CLD0;confirmatory;SK-MEL-5;CHEMBL1964021;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;37;7;CHEMBL614922;;
CLD0;confirmatory;Malme-3M;CHEMBL1964025;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;29;7;CHEMBL614021;;
CLD0;confirmatory;K562;CHEMBL1964030;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;121;7;CHEMBL385;;
CLD0;confirmatory;A498;CHEMBL1964034;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;129;7;CHEMBL614516;;
CLD0;confirmatory;OVCAR-3;CHEMBL1964037;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;99;7;CHEMBL614213;;
CLD0;confirmatory;MOLT-4;CHEMBL1964040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;123;7;CHEMBL614177;;
CLD0;confirmatory;HOP-62;CHEMBL1964043;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;9;7;CHEMBL614643;;
CLD0;confirmatory;NCI/ADR-RES;CHEMBL1964045;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;93;7;CHEMBL613829;;
CLD0;confirmatory;U-251;CHEMBL1964047;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;59;7;CHEMBL615022;;
CLD0;confirmatory;OVCAR-8;CHEMBL1964048;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;109;7;CHEMBL612555;;
CLD0;confirmatory;OVCAR-5;CHEMBL1964049;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;107;7;CHEMBL614214;;
CLD0;confirmatory;SNB-19;CHEMBL1964059;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;53;7;CHEMBL614164;;
CLD0;confirmatory;MDA-MB-231;CHEMBL1964063;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;95;7;CHEMBL400;;
CLD0;confirmatory;SR;CHEMBL1964065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;115;7;CHEMBL614300;;
CLD0;confirmatory;TK-10;CHEMBL1964066;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;141;7;CHEMBL614056;;
CLD0;confirmatory;SW-620;CHEMBL1964072;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;81;7;CHEMBL612262;;
CLD0;confirmatory;NCI-H522;CHEMBL1964075;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;15;7;CHEMBL614387;;
CLD0;confirmatory;KM12;CHEMBL1964077;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;73;7;CHEMBL614709;;
CLD0;confirmatory;M14;CHEMBL1964085;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;25;7;CHEMBL614317;;
CLD0;confirmatory;NCI-H322M;CHEMBL1964087;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;5;7;CHEMBL614803;;
CLD0;confirmatory;RPMI-8226;CHEMBL1964088;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;113;7;CHEMBL614882;;
CLD0;confirmatory;OVCAR-4;CHEMBL1964091;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;105;7;CHEMBL614051;;
CLD0;confirmatory;LOX IMVI ;CHEMBL1964092;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;23;7;CHEMBL614096;;
CLD0;confirmatory;BT-549;CHEMBL1964099;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;89;7;CHEMBL614072;;
CLD0;confirmatory;SK-MEL-2;CHEMBL1963844;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;35;7;CHEMBL614917;;
CLD0;confirmatory;A549;CHEMBL1963854;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;19;7;CHEMBL392;;
CLD0;confirmatory;HCC 2998;CHEMBL1963860;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;77;7;CHEMBL613855;;
CLD0;confirmatory;SNB-75;CHEMBL1963866;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;55;7;CHEMBL614451;;
CLD0;confirmatory;HCT-15;CHEMBL1963868;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;71;7;CHEMBL612263;;
CLD0;confirmatory;HCT-116;CHEMBL1963874;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;79;7;CHEMBL394;;
CLD0;confirmatory;SF-268;CHEMBL1963876;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;45;7;CHEMBL613977;;
CLD0;confirmatory;EKVX ;CHEMBL1963880;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;21;7;CHEMBL614487;;
CLD0;confirmatory;MCF7;CHEMBL1963882;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;83;7;CHEMBL387;;
CLD0;confirmatory;PC-3;CHEMBL1963885;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;41;7;CHEMBL390;;
CLD0;confirmatory;SK-OV-3;CHEMBL1963895;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;103;7;CHEMBL614925;;
CLD0;confirmatory;T47D;CHEMBL1963900;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;91;7;CHEMBL614361;;
CLD0;confirmatory;NCI-H460;CHEMBL1963901;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;7;7;CHEMBL396;;
CLD0;confirmatory;UACC-62;CHEMBL1963903;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;31;7;CHEMBL614610;;
CLD0;confirmatory;CAKI-1;CHEMBL1963911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;131;7;CHEMBL614067;;
CLD0;confirmatory;MDA-MB-435;CHEMBL1963921;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;85;7;CHEMBL614697;;
CLD0;confirmatory;SF-295;CHEMBL1963922;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;47;7;CHEMBL614908;;
CLD0;confirmatory;IGROV-1;CHEMBL1963929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;101;7;CHEMBL613984;;
CLD0;confirmatory;Hs-578T;CHEMBL1963945;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;97;7;CHEMBL614645;;
CLD0;confirmatory;786-0;CHEMBL1963953;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;137;7;CHEMBL613102;;
CLD0;confirmatory;UACC-257;CHEMBL1963960;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;33;7;CHEMBL612796;;
CLD0;confirmatory;CCRF-CEM;CHEMBL1963961;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;119;7;CHEMBL382;;
CLD0;confirmatory;NCI-H226;CHEMBL1964004;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;3;7;CHEMBL614740;;
CLD0;confirmatory;HT-29;CHEMBL1964006;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;65;7;CHEMBL384;;
CLD0;confirmatory;SK-MEL-28;CHEMBL1964007;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;39;7;CHEMBL614919;;
CLD0;confirmatory;RXF 393;CHEMBL1964009;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;133;7;CHEMBL614886;;
CLD0;confirmatory;COLO 205;CHEMBL1964012;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;67;7;CHEMBL614561;;
CLD0;;;CHEMBL2071962;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467794;1;CHEMBL3356;;
CLD0;;;CHEMBL2071963;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467795;1;CHEMBL3397;;
CLD0;;;CHEMBL2071964;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467796;1;CHEMBL3622;;
CLD0;;;CHEMBL2071965;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467797;1;CHEMBL289;;
CLD0;;;CHEMBL2071966;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467798;1;CHEMBL340;;
CLD0;;;CHEMBL2071967;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467799;1;CHEMBL340;;
CLD0;;;CHEMBL2071970;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Metabolic stability in human liver microsomes assessed as low signal/noise ratio (S/N of 1 to 10) by measuring GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis;CHEMBL2069259;Subcellular target assigned;S;467802;1;CHEMBL613373;CHEMBL3559723;
CLD0;;;CHEMBL2071972;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH;CHEMBL2069259;Subcellular target assigned;S;467804;1;CHEMBL613373;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL2075818;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307716;Homologous single protein target assigned;8;TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Prednisone: 200 uM) in MDR1-expressing NIH-3T3 cells;CHEMBL2074246;Homologous protein target assigned;H;2941;18;CHEMBL4302;;
CLD0;;Oocyte;CHEMBL2076196;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Ouabain uptake (Ouabain: 100 uM, Prednisone: 100 uM) in Xenopus laevis oocytes;CHEMBL2074160;Homologous protein target assigned;H;2040;18;CHEMBL1781859;;
CLD0;;LLC-PK1;CHEMBL2076064;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport in MDR1-expressing LLC-PK1 cells;CHEMBL2074008;Homologous protein target assigned;H;90;18;CHEMBL4302;;
CLD0;confirmatory;;CHEMBL2114890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651741;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL2114895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule activators of the p53 signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651743;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114797;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651751;7;CHEMBL2146315;;
CLD0;confirmatory;;CHEMBL2114842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651802;7;CHEMBL1741186;;
CLD0;;LLC-PK1;CHEMBL2344479;[];Sus scrofa;[];;;9823.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307655;Target assigned is non-molecular;1;Efflux ratio of permeability from basolateral to apical side over apical to basolateral in pig LLC-PK1 cells overexpressing human MDR1 relative to efflux ratio in parental cell line;CHEMBL2331179;Non-molecular target assigned;N;558404;1;CHEMBL614577;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;;CHO;CHEMBL3039488;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;1;1;CHEMBL1697668;;
CLD0;;CHO;CHEMBL3039491;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;4;1;CHEMBL1743121;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;L1210;CHEMBL3254086;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells assessed as growth inhibition measured at 72 hrs by trypan blue exclusion assay;CHEMBL3244344;Non-molecular target assigned;N;658467;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254092;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '27.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '27.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 27 mg/kg, ip qd administered for 5 days (Rvb = 10 days);CHEMBL3244344;Non-molecular target assigned;N;658505;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254099;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '27.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '27.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 27 mg/kg, ip qd administered for 5 days relative to control;CHEMBL3244344;Non-molecular target assigned;N;658515;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254575;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '27.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '27.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];C3D2F1/J;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 27 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g);CHEMBL3244344;Non-molecular target assigned;N;658536;1;CHEMBL375;;
CLD0;;;CHEMBL3253075;[{'assay_class_id': 517, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Adrenalectomy in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 525, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Liver Glycogen Depostion Test in Rats', 'source': 'Vogel_2008'}];Rattus norvegicus;[];;;10116.0;;Liver;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Glucocorticoid activity in sc dosed bilaterally adrenalectomized rat assessed as glycogen deposition in liver administered for 5 days relative to cortisol;CHEMBL3244262;Non-molecular target assigned;N;666505;1;CHEMBL376;CHEMBL3559723;
CLD0;;;CHEMBL3411290;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732530;1;CHEMBL1697668;;
CLD0;;;CHEMBL3411292;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732532;1;CHEMBL1743121;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
GP_020;;;CHEMBL4296184;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_001;;;CHEMBL4296185;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
GN_034;;;CHEMBL4296188;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_TOU;;Vero C1008;CHEMBL4303819;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs;CHEMBL4303097;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1073329;;;CHEMBL4334301;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability of the compound at 100 uM after 6 hrs by PAMPA;CHEMBL4330180;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
1096599;;;CHEMBL4340448;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of LPS-stimulation dependent TLR4-induced NF-kappaB/AP-1 signaling cascade in human THP1-XBlue-MD2-CD14 cells at 1 uM pre-incubated for 1 hr before LPS-stimulation for 24 hrs by spectrophotometry;CHEMBL4339252;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1214635;;;CHEMBL4630432;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Balb/c mouse model of collagen-induced arthritis assessed as reduction in degree of cartilage and bone destruction and inflammation at 5 mg/kg, ig for 2 weeks by H and E staining based histopathological analysis;CHEMBL4627410;Non-molecular target assigned;N;;1;CHEMBL375;;
1214656;;;CHEMBL4630438;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Balb/c mouse model of Imiquimod-induced psoriasis-like skin lesions assessed as reduction of serum IL-1beta level at 5 mg/kg, ig by ELISA;CHEMBL4627410;Non-molecular target assigned;N;;1;CHEMBL375;;
1214657;;;CHEMBL4630439;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Balb/c mouse model of Imiquimod-induced psoriasis-like skin lesions assessed as reduction of serum IL6 level at 5 mg/kg, ig by ELISA;CHEMBL4627410;Non-molecular target assigned;N;;1;CHEMBL375;;
1273080;;HEK293T;CHEMBL4680589;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as effective dissociation constant measured every 130 sec for 22 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1273084;;REH;CHEMBL4680590;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308823;Target assigned is non-molecular;1;Cytotoxicity against human REH cells overexpressing GR assessed as reduction in cell viability measured after 3 days by resazurin based assay;CHEMBL4680066;Non-molecular target assigned;N;;1;CHEMBL2366320;;
1273278;;HEK293T;CHEMBL4680591;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as the time at which half of the GFP-GR is translocated to the nucleus measured every 7 to 8 sec for 10 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1273279;;HEK293T;CHEMBL4680592;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as the time at which half of the GFP-GR is translocated to the nucleus measured every 130 sec for 22 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1286551;;;CHEMBL4709012;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug absorption of the compound incubated for 8 hrs by PAMPA-TGI assay;CHEMBL4706524;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1286548;;;CHEMBL4709013;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability of the compound incubated for 8 hrs by PAMPA-TGI assay;CHEMBL4706524;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1286556;;;CHEMBL4709032;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability of the compound by PAMPA-TGI assay;CHEMBL4706524;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1276288;;A-375;CHEMBL4770313;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308077;Target assigned is non-molecular;1;Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4765330;Non-molecular target assigned;N;;1;CHEMBL613859;;
1276303;;HT-29;CHEMBL4770314;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT29 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4765330;Non-molecular target assigned;N;;1;CHEMBL384;;
1276305;;MCF7;CHEMBL4770315;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4765330;Non-molecular target assigned;N;;1;CHEMBL387;;
1276313;;FaDu;CHEMBL4770317;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307943;Target assigned is non-molecular;1;Cytotoxicity against human FaDu cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4765330;Non-molecular target assigned;N;;1;CHEMBL612250;;
1276315;;NIH3T3;CHEMBL4770318;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Target assigned is non-molecular;1;Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay;CHEMBL4765330;Non-molecular target assigned;N;;1;CHEMBL614822;;
